학술논문

Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001
Document Type
Article
Source
In Annals of Oncology July 2019 30(7):1121-1126
Subject
Language
ISSN
0923-7534